Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma.
Chin CK, Rodriguez MA, Qing Y, Feng L, Samaniego F, Jain P, Noorani M, Fowler NH, Fayad LE, Westin JR, Neelapu SS, Hagemeister FB, Flowers CR, Nastoupil LJ. Chin CK, et al. Among authors: westin jr. Leuk Lymphoma. 2020 Dec;61(12):2985-2989. doi: 10.1080/10428194.2020.1789631. Epub 2020 Jul 6. Leuk Lymphoma. 2020. PMID: 32628087 No abstract available.
Vive la résistance: stem cells in mantle cell lymphoma.
Davis RE, Westin JR. Davis RE, et al. Among authors: westin jr. Leuk Lymphoma. 2011 Jun;52(6):944-5. doi: 10.3109/10428194.2011.569622. Epub 2011 Apr 4. Leuk Lymphoma. 2011. PMID: 21463111 No abstract available.
Therapy of newly diagnosed follicular lymphoma.
Westin JR, Neelapu SS. Westin JR, et al. Front Oncol. 2012 Dec 11;2:188. doi: 10.3389/fonc.2012.00188. eCollection 2012. Front Oncol. 2012. PMID: 23248775 Free PMC article.
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial.
Westin JR, Thompson MA, Cataldo VD, Fayad LE, Fowler N, Fanale MA, Neelapu S, Samaniego F, Romaguera J, Shah J, McLaughlin P, Pro B, Kwak LW, Sanjorjo P, Murphy WA, Jimenez C, Toth B, Dong W, Hagemeister FB. Westin JR, et al. Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):99-105. doi: 10.1016/j.clml.2012.11.002. Epub 2012 Dec 29. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23276888 Free PMC article. Clinical Trial.
Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
Oki Y, Westin JR, Vega F, Chuang H, Fowler N, Neelapu S, Hagemeister FB, McLaughlin P, Kwak LW, Romaguera JE, Fanale M, Younes A, Rodriguez MA, Orlowski RZ, Wang M, Ouzounian ST, Samaniego F, Fayad L. Oki Y, et al. Among authors: westin jr. Br J Haematol. 2013 Dec;163(5):611-20. doi: 10.1111/bjh.12585. Epub 2013 Oct 1. Br J Haematol. 2013. PMID: 24117234 Free PMC article. Clinical Trial.
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.
Westin JR, Chu F, Zhang M, Fayad LE, Kwak LW, Fowler N, Romaguera J, Hagemeister F, Fanale M, Samaniego F, Feng L, Baladandayuthapani V, Wang Z, Ma W, Gao Y, Wallace M, Vence LM, Radvanyi L, Muzzafar T, Rotem-Yehudar R, Davis RE, Neelapu SS. Westin JR, et al. Lancet Oncol. 2014 Jan;15(1):69-77. doi: 10.1016/S1470-2045(13)70551-5. Epub 2013 Dec 11. Lancet Oncol. 2014. PMID: 24332512 Free PMC article. Clinical Trial.
Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.
Westin JR. Westin JR. Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):335-42. doi: 10.1016/j.clml.2014.01.007. Epub 2014 Feb 7. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24650973 Free PMC article. Review.
128 results